|
Biogen Idec presenterà all’ECTRIMS numerosi nuovi dati relativi alla suo ampia …
ANSA.it PROCESSO DACLIZUMAB AD ELEVATO RENDIMENTO (DAC HYP): in fase di sviluppo come iniezione sottocutanea da somministrare mensilmente. Si ritiene che DAC HYP abbia come target le cellule immunitarie attive che possono giocare un ruolo … |
BIOGEN IDEC INC : Biogen Idec to Present Extensive New Data from Its Robust …4-traders (press release)DACLIZUMAB HIGH-YIELD PROCESS (DAC HYP): is being developed as a once-monthly subcutaneous injection. DAC HYP is believed to target the activated im…
Intramed.net (Suscripción) |
Calambres nocturnos en las piernas
Intramed.net (Suscripción) Otros fármacos relacionados con calambres en las piernas son: daclizumab, levalbuterol, albuterol, ipratropio, pregabalina, bromocriptina, bupropión, celecoxib, cetirizina), cromo, cinacalcet, ciprofloxacina, donepecilo, eszopiclona, fluoxetina … |
Glomerular C1q deposition and serum anti-C1q antibodies in anti-glomerular …7thSpace Interactive (press release)Recently, anti-C1q antibodies are demonstrated to be pathogenic in the target organ damage of many autoimmune diseases, by facilitating C1…
|
Heterophile Antibodies Can Cause False Positives on Some Thyroid Tests
About – News & Issues My work as a patient advocate proves to me time and again that we thyroid patients owe it to ourselves to use the Internet to stay abreast of the latest developments — and use social media to stay connected with each other — so that we can all be … |
InDi Spinoff Gets $1.5M, Aims to Beat Antibodies in DiagnosticsXconomySeattle-based InDi, aka Integrated Diagnostics, is planning to graduate from startup mode this year and start selling its first product, a diagnostic test that spots lung cancer in a…
|
Indi Molecular Launches With $1.5 Million Seed Round Led by Interwest Partners
MarketWatch (press release) The funds will be used to further develop PCC (protein catalyzed capture) agent technology: a breakthrough process that produces synthetic peptide molecules capable of binding interactions that are equivalent or superior to molecular antibodies. PCCs … Integrated Diagnostics Spinout Indi Molecular Seeded With $1.5MDow Jones Bankruptcy & Debt (registration) |
Clinical Oncology NewsLenalidomide Indication Expanded To Include MCLClinical Oncology NewsThe expanded indication is based on the results of MCL-001, a Phase II, multicenter, open-label, single-arm trial that included 134 patients with MCL who had rec…
Drug Discovery & Development |
FDA OKs Teva’s New Treanda Liquid Formulation
Drug Discovery & Development Treanda is indicated for use in patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen, and in patients with chronic lymphocytic leukemia (CLL). |
Second edition of Antibodies: An essential resource for molecular biology …News-Medical.netThe now classic lab manual Antibodies, by Harlow and Lane, has been revised, extended, and updated by Edward Greenfield of the Dana-Farber Cancer Center, with …